oleanolic acid has been researched along with cardiovascular agents in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nadar, A; Rammanan, P; Shode, FO; Somova, LO | 1 |
| Cui, T; Mathis, BJ | 1 |
| Pawełczyk, A; Zaprutko, L | 1 |
1 review(s) available for oleanolic acid and cardiovascular agents
| Article | Year |
|---|---|
CDDO and Its Role in Chronic Diseases.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Cardiovascular Agents; Chronic Disease; Drug Discovery; Gene Expression Regulation; Humans; Medicine, Chinese Traditional; Molecular Structure; Oleanolic Acid; Phytotherapy; Plants, Medicinal; Signal Transduction; Structure-Activity Relationship | 2016 |
2 other study(ies) available for oleanolic acid and cardiovascular agents
| Article | Year |
|---|---|
Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension.
Topics: Animals; Antioxidants; Artemia; Blood Pressure; Cardiovascular Agents; Heart Rate; Hypolipidemic Agents; Male; Models, Animal; Oleanolic Acid; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Syzygium; Triterpenes; Ursolic Acid | 2003 |
Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives.
Topics: Antiviral Agents; Betacoronavirus; Cardiovascular Agents; Coronavirus Infections; COVID-19; Drug Repositioning; Drugs, Chinese Herbal; Humans; Oleanolic Acid; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |